{"name":"Medical Dermatology Specialists","slug":"medical-dermatology-specialists","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Levulan® Kerastick®","genericName":"Levulan® Kerastick®","slug":"levulan-kerastick","indication":"Actinic keratosis (non-hyperkeratotic, non-hypertrophic lesions on face and scalp)","status":"marketed"}]}],"pipeline":[{"name":"Levulan® Kerastick®","genericName":"Levulan® Kerastick®","slug":"levulan-kerastick","phase":"marketed","mechanism":"Levulan (aminolevulinic acid) is a photosensitizing agent that accumulates in skin lesions and generates reactive oxygen species when activated by blue light, destroying abnormal cells.","indications":["Actinic keratosis (non-hyperkeratotic, non-hypertrophic lesions on face and scalp)","Actinic keratosis (hyperkeratotic and hypertrophic lesions on face and scalp) when used with occlusion"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQMENGZnotRGN2SVJPd2FYSXp0NlFmQlVJV1FKWHhZSDVxZ1gxWUhQU1lNQWxtcGtsNERUdlk1OXJBNlp4RlZyWlExc1VZaVZOa1BfczBDMUhITGlvVnNwa25hRDQtRUJ6SllxVExKbFBfUHVSQl9aMjQtNjhBZVYwQ3d5VVpHVFZCcDJFeUJQRUdrY21hdEUwMUVBV2d2N0hDVXJ5TTZNMkxfWXVHQXZ3SWdBRkhtUWRzUGZieGxTQ0s0R0NEN1hqeA?oc=5","date":"2026-03-12","type":"pipeline","source":"AD HOC NEWS","summary":"Almirall Aktie (ES0157097017): Dermatology-focused mid-cap under scrutiny by global healthcare inves - AD HOC NEWS","headline":"Almirall Aktie (ES0157097017): Dermatology-focused mid-cap under scrutiny by global healthcare inves","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxOTi1ORDZWZVhFNzdkVzBrdXVEZm1wYkVIaDcxMVBWbjFPS203aFRBNzJxTm5JV0h1b1pycWhWR0xCRFVOWDN6czFXZ3doampoRnV3TG00d0QtRHc2bTBSWGpDenJmZW1DdGhqREZQclFSQTNCQTVFQk5EWng2dGxZLUtjNHdqSGtOR3dGS2VjQUV1eTVkUF9yRXItNWF3eENDLThiYTl5ZHdleFFKeVByMWFCT0kxUlNDZ183OWkybk1yZw?oc=5","date":"2026-01-13","type":"deal","source":"fiercepharma.com","summary":"JPM26: Leo Pharma, hungry for more partnerships, looks to widen reach in rare dermatology diseases - fiercepharma.com","headline":"JPM26: Leo Pharma, hungry for more partnerships, looks to widen reach in rare dermatology diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQLW5BRzlxbm9MN3ctTzNfd1Y0SEg0NmtYUkFvLW80X05kRTlMZTZOVjNKaTJJVDg3U3Vva0M5M3R5bXo5SlEtSnE5d0ZkVXVLRGpOVHRtN0NuSE5Uekoyb2Z1c0VubGFmbHZyWEd3UThrM01saC1SY1NOWHQtTHpvb3M5QXdfak9ZcEU0dlkzdE1tUGhxRnFXZ0dVZzJNSVhRYS14RXRWamg1el9ZYUFNSUg2RQ?oc=5","date":"2026-01-07","type":"pipeline","source":"BioSpace","summary":"LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference - BioSpace","headline":"LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxQeVo2UUNzQkxySmlDRmR2TEtMNGE0YXRsdy00bjNYaEwyRVFjaktDYkh4dHliRFU4a1FMazZFOTBRcjVVTnFUeDhSNEpLNnltXy05c2hYOTF4TFFtVW9ZRU1NMmVucVBtUVZXenluWHFLeDNQQkhWQk1GMTZKUGEwaG4zYXVIU0dFaW1sRE11Q3NuZ2lWSkVEUFV6Zjg4Q2g0Q3JhVE1tVERiOWFYaV9DX3Y1MTlwTDkyS190WHFiVEh1LVNjNnZDQUpXUDJrV29Jdk5yazZWNTJ4bjNwU1hYeDBTVQ?oc=5","date":"2026-01-07","type":"pipeline","source":"Via Ritzau","summary":"LEO Pharma to present at the 44th annual J.P. Morgan Healthcare Conference - Via Ritzau","headline":"LEO Pharma to present at the 44th annual J.P. Morgan Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxPaXZUMlRLT28zZG9SdDB4X1dwdUlqSVFHMVdxLUhMUk1zTDJPNG1PMWZTUFpJVkl3V1NpeVVKdjhMc0kwYm1Ic1VlajN0YXRGcC04OUZxajFXTldsV2hDMXZodkt3S21BbGt4S2JhVkk4TVJrN1NtckNxVjdxQWhqTGFaV1R2SDEyZkx0cThVUEVWWmNvVHF6SXpJdjVZdW0xclhaMWZmOGV6Nmg3bWlUSm5LYjVVMFlxX3M1SEUwVGF6Q0tDc3EtbXdXa0Jod2FYa29nLS1IWk1FODRoYzdzUzUxOFZxdGpPTjg0aXNJTzRhMmJVV1ZDNVpWTjl2QlV4V04wUzZ0Mm1DTWtzUDd6V3Ywc1ZQQXRHWFRtNmlFelY3dkxwQlE?oc=5","date":"2025-11-03","type":"pipeline","source":"Via Ritzau","summary":"LEO Pharma strengthens leadership in medical dermatology with the appointment of Sophie Lamle as Chief Development Officer - Via Ritzau","headline":"LEO Pharma strengthens leadership in medical dermatology with the appointment of Sophie Lamle as Chief Development Offic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNYmM2SEI1aFRRX3NyT1lUYVctclMtLXB4MkQwU2FIRmFKYzhJazI2ai1Mc3phMG9PaUtCTUd5OGpzQ0Z5Vk5iV0oweGF0V0FzT1c3eFZkOGQ3N2xTaVBxS0Q3T3M1Y3JTSmtkbUhZeHp0TzJEUUZpM3RVbVBVQkhOQVBpN3hvZDJoZHhEUGNEcXNvWktucmc?oc=5","date":"2025-07-17","type":"pipeline","source":"Mexico Business News","summary":"Addressing Dermatology Challenges in Mexico: LEO Pharma - Mexico Business News","headline":"Addressing Dermatology Challenges in Mexico: LEO Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNZ0RJcVI0aEs4ZHdDT2pkTFRwUjZkcGRCUG96TWdRNEdzMnJBNjRfOXVfVmNDWGpZVERuYUFVMUZHaENUQ0N5ZjFiMFNMZWpPS0M3ZERrSmxZeHkzcmd2TDZZbmNqM1BZa0swVkJ4WTdKM1NOV0podVdjTXMzTHA1QmxKUGszU0VLSWRLYk5yZFV3NFd4ZllNdVU4d2sxZm9tOC1LMDV2ZnJ1akk2cDQ2UUtaN2w1OG9zZ000Uy1tV0tFNzA?oc=5","date":"2025-07-14","type":"pipeline","source":"bloomberg.com","summary":"LEO Pharma Adds Skin Drug from Boehringer as It Readies for IPO - bloomberg.com","headline":"LEO Pharma Adds Skin Drug from Boehringer as It Readies for IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOU2IxNEYwQjJIS1psWGhhX3NPOTlJNWo4VjBNT1JvUmpyRFhPU3o4SFlqMlJHaFkxeE5MMVV4Vk5YYXpWTW1XbXBLc1dmVWlHcVBfUFZVWXEyWlhPa2xnWFNBV0RsMHV4aXdCNG1hMWdQODl2RHFlbU5lTUlEMVBkcE9VdFJZYTNMLThSbVZCa0NZZEN4c2wtUGN0NzZGM0dYbUlqb2wySF9vTDBvUXp3dnFNdXRXZw?oc=5","date":"2025-04-08","type":"pipeline","source":"Medscape Reference","summary":"Atopic Dermatitis Care: Is It Time to Call a Specialist? - Medscape Reference","headline":"Atopic Dermatitis Care: Is It Time to Call a Specialist?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQbF9kdkFHaGR5YzZPRWhtRGNqM3kyN2NTdV94aDBJcGItRkVYWndUSG93c3djLXkyQ0tEbDU3aWRmeHlCMnFudHdZTTg3X2x6cEVIX2VlaXJkQWd0RUppaERSY2pWREZURkYyNXhfZno3c1JRcFpaajhQZTY0cFJaTVp0b0Jva3FSdGJNRHRRWkxxSUpwZ1hzMUR3?oc=5","date":"2025-01-11","type":"deal","source":"Fierce Biotech","summary":"Gilead roars into JPM25, inking $1.7B inflammation deal with Leo Pharma - Fierce Biotech","headline":"Gilead roars into JPM25, inking $1.7B inflammation deal with Leo Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOd0htUW0xSnNuTW9aWFZTQjZwT3ZTX05aX2FBUWJhZDdhX05wS1k5WFlfbVZURTNYb2FXb2EtRThvUkpqUkx0VG5FZEE5UUROYWxrSjJPRW5VTGREdG15SHJSNDF0bnBxbUJDY1NlUjU5RTdMNlo3MDVZWUdfcGxxNEFjcXdnY2p4WFNkeG5n?oc=5","date":"2023-10-26","type":"pipeline","source":"Private Equity Stakeholder Project PESP","summary":"Private Equity Healthcare Acquisitions – September 2023 - Private Equity Stakeholder Project PESP","headline":"Private Equity Healthcare Acquisitions – September 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPVFRSQS1lemFrc0pqUnBwbzhMS0k2Uk14VFJZOWZpeGhoNUNoRmZDdlVSUnZjbV9MRERqWTF5cG1wYUpsYkIwWkdETWFXSGNWX3FtbUFZaHZhODVwYTVaX0RyeHJubnpRT1hxclV0THYwaDJwT1lPU1hYM2JhRllqOHhMZElyTlktcm0yRWVwU0ROZ2lOU2hlNG5lbw?oc=5","date":"2022-07-29","type":"pipeline","source":"Veeva","summary":"Global Pharma Company Modernizes Medical Information Management - Veeva","headline":"Global Pharma Company Modernizes Medical Information Management","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPcGRCb1h2Njl0TV9oNllUYXFKNVVMQ0dodnp4Yld5bF90cEpEaFcxbFV0OHVWVUoyYk9UN0ZiWFVUaUtFTE80MFJLRFBpaHJ0enY4anhjUXVqLUdRVm9UVE1wSHZsNkRKX0pVUDZvNy1GdWpDSW1rcGo1WXFobENPejRGVlRMRmw1MnFTVVY0ZE5Wdmoy?oc=5","date":"2021-07-08","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Sandoz to gain generic dermatology specialist Fougera - Generics and Biosimilars Initiative","headline":"Sandoz to gain generic dermatology specialist Fougera","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}